Edition:
United States

Proteon Therapeutics Inc (PRTO.OQ)

PRTO.OQ on NASDAQ Stock Exchange Global Market

2.25USD
23 Apr 2018
Change (% chg)

$-0.05 (-2.17%)
Prev Close
$2.30
Open
$2.35
Day's High
$2.35
Day's Low
$2.25
Volume
1,285
Avg. Vol
9,389
52-wk High
$2.85
52-wk Low
$1.15

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Dec '17 0.00 -0.315
Sep '17 0.00 -1.084
Jun '17 0.00 -0.326
Mar '17 0.00 -0.391
FY 2016 Dec '16 0.00 -0.420
Sep '16 0.00 -0.429
Jun '16 0.00 -0.477
Mar '16 0.00 -0.397
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Jun-18 2 0.00 0.00 0.00 --
Quarter Ending Sep-18 2 0.00 0.00 0.00 --
Year Ending Dec-18 3 0.00 0.00 0.00 0.00
Year Ending Dec-19 4 16.58 63.80 0.00 10.12
Earnings (per share)
Quarter Ending Jun-18 5 -0.35 -0.29 -0.48 -0.34
Quarter Ending Sep-18 5 -0.36 -0.29 -0.49 -0.37
Year Ending Dec-18 5 -1.42 -1.18 -1.92 -1.36
Year Ending Dec-19 5 -1.28 -0.75 -1.48 -0.91
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 185.04 32.78
P/E High - Last 5 Yrs. -- 284.68 45.94
P/E Low - Last 5 Yrs. -- 95.75 24.95
Beta 1.52 0.75 0.80
Price to Sales (TTM) -- 136.40 7.08
Price to Book (MRQ) 3.08 19.34 5.00
Price to Tangible Book (MRQ) 1.14 24.06 6.75
Price to Cash Flow (TTM) -- 122.96 25.60
% Owned Institutions 75.00 11.18 2.21

Dividends

  Company industry sector
Dividend Yield -- 0.29 1.55
Dividend Yield - 5 Year Avg -- 0.20 0.74
Dividend 5 Year Growth Rate -- 1.94 3.92
Payout Ratio(TTM) -- 9.18 20.28

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 103.99 9.00
Sales (TTM) vs TTM 1 Yr. Ago -- 80.63 10.85
Sales - 5 Yr. Growth Rate -- 33.87 8.21
EPS (MRQ) vs Qtr. 1 Yr. Ago 24.92 -66.82 22.25
EPS (TTM) vs TTM 1 Yr. Ago -22.84 -- --
EPS - 5 Yr. Growth Rate -- 47.44 10.24
Capital Spending - 5 Yr. Growth Rate -12.18 45.48 10.39

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.63 2.53
Current Ratio (MRQ) 4.71 5.97 3.62
LT Debt to Equity (MRQ) 0.00 23.32 11.28
Total Debt to Equity (MRQ) 0.00 25.75 13.94
Interest Coverage (TTM) -- -181.71 30.08

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 36.28 53.98
Gross Margin - 5 Yr. Avg. -- 55.36 52.10
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -3,197.22 -149.35 15.94
Operating Margin (TTM) -- -564.83 4.32
Operating Margin - 5 Yr. Avg. -3,210.28 -161.27 11.31
Pre-Tax Margin (TTM) -- -537.64 4.97
Pre-Tax Margin - 5 Yr. Avg. -3,090.94 -168.32 11.62
Net Profit Margin (TTM) -- -526.60 1.58
Net Profit Margin - 5 Yr. Avg. -3,090.94 -168.70 7.94
Effective Tax Rate (TTM) -- -0.44 31.27
Effective Tax Rate - 5 Yr. Avg. -- 18.13 24.27

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 23,918,133 819,537,692
Net Income/Employee (TTM) -- 754,796 96,346,718
Receivable Turnover (TTM) -- 6.24 5.57
Inventory Turnover (TTM) -- 2.37 3.45
Asset Turnover (TTM) 0.00 0.40 0.89

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -68.49 -0.77 10.55
Return on Assets - 5 Yr. Avg. -40.07 0.69 11.58
Return on Investment (TTM) -81.89 -0.74 13.21
Return on Investment - 5 Yr. Avg. -45.37 4.20 14.99
Return on Equity (TTM) -142.13 -2.80 15.01
Return on Equity - 5 Yr. Avg. -234.41 -0.05 16.27
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % -23.38 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Proteon Therapeutics Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 75.00%
# of Holders: 37
Total Shares Held: 13,256,427
3 Mo. Net Change: 2,029
# New Positions: 1
# Closed Positions: 0
# Increased Positions: 2
# Reduced Positions: 0
# Net Buyers: 2
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.